Posted on 12/16/20
Ocular Therapeutix Prices Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/16/20
Forma Therapeutics Closes Public Offering
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of an underwritten . . .
Posted on 12/16/20
Maryland Surpasses 5,000 COVID-19 Deaths as Coronavirus Hospitalizations Reach Record High for Fifth Time in a Week
More than 5,000 Marylanders have died from coronavirus-related complications since the beginning of the pandemic, with the state reporting 61 more deaths on Tuesday.With that, Maryland . . .
Posted on 12/16/20
Philly Scientists Were Just Awarded $37.6M to Develop a COVID-19 Antibody Treatment
A collaborative team of scientists from institutions across Philadelphia and the country just received a $37.6
Posted on 12/16/20
Maryland’s Federal Agencies & Military Installations at the Heart of COVID-19 Research
As the world combats COVID-19, researchers and scientists have been working tirelessly to understand the virus and its implications on health, the economy, and everything in . . .
Posted on 12/15/20
EmendoBio Acquired by AnGes
EmendoBio Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, today announced that AnGes, Inc.,
Posted on 12/15/20
Radius Health Provides Business Update
WALTHAM, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) provided a general business update on progress made since October 2020. The key . . .
Posted on 12/15/20
Idera Pharmaceuticals Announces $5M In Further Proceeds from Private Placement of up to $20.7M
EXTON, Pa., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the closing of a second tranche under its April 7, 2020, . . .
Posted on 12/15/20
Welltower and Wafra Announce $550 Million Medical Office Building Joint Venture
Wafra Inc., a global alternative investment platform, and Welltower Inc. (NYSE: WELL), an S&P 500 healthcare real estate investment trust (REIT), today announced a $550 million . . .
Posted on 12/15/20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
BOSTON, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative . . .
Posted on 12/15/20
Va. COVID-19 Rates Climbing as Vaccines are Released
Virginia’s COVID-19 numbers continue to climb, with 26,279 more cases and 206 deaths recorded last week, according to the Virginia Department of Health’s Dec. 14 update.The . . .
Posted on 12/15/20
Va. Hospital Systems Begin Receiving COVID Vaccine Shipments
Sentara Healthcare and Bon Secours Health System received portions of the state’s first shipment of Pfizer Inc.’s COVID-19 vaccine Monday, and other health systems in the . . .
Posted on 12/15/20
Eli Lilly to Acquire Prevail Therapeutics
Eli Lilly and Company (NYSE: LLY) and Prevail Therapeutics Inc. (NASDAQ: PRVL) today announced a definitive agreement for Lilly to acquire Prevail for $22.50 per share . . .
Posted on 12/15/20
When Will Pfizer and Moderna Recognize COVID Vaccine Revenue?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) are waiting on pins and needles to receive emergency use authorizations (EUA) for their COVID-19 vaccines. And investors are anxiously awaiting the big . . .
Posted on 12/15/20
Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Merck(NYSE:MRK) was one of the earliest investors in Moderna(NASDAQ:MRNA), buying a position in the biotech even before it went public in late 2018. Earlier this month, . . .
Posted on 12/15/20
Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?
Reports emerged recently that the Trump administration turned down an opportunity to secure more doses of Pfizer(NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine, BNT162b2. In this Motley . . .
Posted on 12/15/20
When Will Pfizer and Moderna Recognize COVID Vaccine Revenue?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) are waiting on pins and needles to receive emergency use authorizations (EUA) for their COVID-19 vaccines. And investors are anxiously awaiting the big . . .
Posted on 12/15/20
Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Merck(NYSE:MRK) was one of the earliest investors in Moderna(NASDAQ:MRNA), buying a position in the biotech even before it went public in late 2018. Earlier this month, . . .
Posted on 12/14/20
Arvinas Announces Proposed Offering of Common Stock
NEW HAVEN, Conn., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 12/14/20
Rocket Pharmaceuticals Closes Public Offering
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the . . .
Posted on 12/14/20
Ocular Therapeutix Proposes Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/14/20
Ambu Awarded Single-Use Endoscopy Contract with U.S. Group Purchasing Organization
COLUMBIA, Md.--(BUSINESS WIRE)--Ambu Inc., the world leader in single-use endoscopes, announced today that it has been granted a national single-use endoscopy contract in the category of . . .
Posted on 12/14/20
Coronavirus Hospitalizations in Maryland Reach Record High for Fourth Time in Past Week
Maryland’s coronavirus-related hospitalizations on Monday reached a record high for the fourth time in the past week.There are currently 1,742 Marylanders hospitalized due to COVID-19, the . . .
Posted on 12/14/20
CareFirst, Baltimore Health Department to Host Free Flu Shot Clinics
CareFirst BlueCross BlueShield and the Baltimore City Health Department will host free flu shot clinics on Dec. 14 at Fort Worthington Elementary School and Dec. 15 . . .
Posted on 12/14/20
Seelos Therapeutics Raises $10 Million
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases

